14/04/2021 - 07:30 Portefeuille Gimv partners with Apraxon to support the company’s growth ambitions En savoir plus
17/03/2021 - 07:40 Portefeuille Gimv invests in Verkley, a specialist contractor in cable and pipeline networks for energy and water En savoir plus
17/03/2021 - 07:30 Portefeuille Consortium around EMERAM and Gimv to support German digital learning platform sofatutor in the next growth phase En savoir plus
08/03/2021 - 17:45 Financier Gimv pioneers with a sustainable finance framework, resulting in the successful issue of a first sustainable bond En savoir plus
25/02/2021 - 09:00 Portefeuille Kind Technologies starts joint venture named HORTILOGICS B.V. En savoir plus
15/02/2021 - 13:30 Corporate news 100x100 - CEO Koen Dejonckheere in conversation with Wassim Essebane En savoir plus
29/01/2021 - 07:30 Financier Gimv announces share buyback in the context of a share purchase plan for its personnel En savoir plus
21/01/2021 - 10:00 Portefeuille Biotalys submits first protein-based biocontrol registration package to the EPA En savoir plus
19/01/2021 - 14:30 Portefeuille Gimv sells OTN Systems, a provider of telecommunication solutions for industrial markets, to listed Belden Inc. En savoir plus
10/12/2020 - 11:00 Portefeuille Cegeka and Citymesh join forces to form a fourth national operator in Belgium En savoir plus
02/12/2020 - 07:30 Portefeuille Gimv sells Itho Daalderop-Climate for Life - Dutch market leader in integrated sustainable solutions for energy-neutral living in the Benelux - to Parcom En savoir plus
30/11/2020 - 08:00 Portefeuille Gimv is founding investor of Kinaset Therapeutics in a USD 40m Series A round – funds used to develop novel therapeutics for respiratory diseases En savoir plus
25/11/2020 - 09:00 Portefeuille Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market En savoir plus
19/11/2020 - 07:30 Portefeuille Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors En savoir plus
11/11/2020 - 13:00 Portefeuille ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01 En savoir plus
06/11/2020 - 08:10 Portefeuille Le groupe Köberl lance une initiative de croissance avec l'acquisition de 089 Immobilienmanagement GmbH En savoir plus
22/10/2020 - 17:55 Portefeuille Gimv and founder sell Eurocept Homecare - active in ’Hospital-at-home‘ services and complex wound care - to Mediq En savoir plus
19/10/2020 - 09:18 Portefeuille Topas Therapeutics raises EUR 22 Million in Series B Financing and appoints new CEO En savoir plus
01/10/2020 - 07:30 Portefeuille Gimv soutient Daniel Attias et Didier Thibaud dans la construction d’un challenger régional de la biologie médicale En savoir plus
30/09/2020 - 12:07 Portefeuille 2020 09 29 - Repositionnement plus écologique pour le groupe AgroBiothers En savoir plus
30/09/2020 - 11:48 Corporate news Gimv is 40: Wij doen wat veel fondsen niet durven' Uit Trends van 24/09/2020 En savoir plus
15/09/2020 - 11:19 Portefeuille ImCheck Announces Investment by BB Pureos Bioventures to Close Series B Fundraising with Total of €54 million ($64 million) En savoir plus
